Cover Image

Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Jeffrey J Ellis,1 Alesia B Sadosky,2 Laura L Ten Eyck,1 Joseph C Cappelleri,2 Courtney R Brown,3 Brandon T Suehs,1 Bruce Parsons2 1Comprehensive Health Insights Inc., Louisville, KY, USA; 2Pfizer Inc., New York, NY, USA; 3Humana Inc., Louisville, KY, USA Purpose: To examine the impact of newly initi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ellis JJ (Author), Sadosky AB (Author), Ten Eyck LL (Author), Cappelleri JC (Author), Brown CR (Author), Suehs BT (Author), Parsons B (Author)
Format:	Book
Published:	Dove Medical Press, 2014-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the Efficacy of Duloxetine Versus Pregabalin for Pain Relief of Neuropathy in Diabetics
by: Hamid Raza Gulzar, et al.
Published: (2024)

Effect of Pregabalin Combined with Duloxetine and Tramadol on Allodynia in Chronic Postischemic Pain and Spinal Nerve Ligation Mouse Models
by: Jie Quan, et al.
Published: (2022)

A systematic review of the effectiveness of policies restricting access to pregabalin
by: Brett R. Stacey, et al.
Published: (2017)

Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial-BLOSSOM
by: Martin Rakusa, et al.
Published: (2023)

Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial
by: Mansoor Shakiba, et al.
Published: (2018)

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial
by: Himanshu P. Upadhyaya, et al.
Published: (2019)

Pregabalin and other antiepileptic drugs in chronic neuropathic pain
by: Paolo Marchettini
Published: (2017)

Evaluating increased resource use in fibromyalgia using electronic health records
by: Margolis JM, et al.
Published: (2016)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
by: Asiimwe IG, et al.
Published: (2022)

Stability-Indicating Spectrophotometric Methods for Determination of Milnacipran HCl and Duloxetine HCl in Bulk Drug and Pharmaceutical Formulations
by: Maha F. Abdel Ghany, et al.
Published: (2019)

Measurement properties of painDETECT by average pain severity
by: Cappelleri JC, et al.
Published: (2014)

Characterizing individual painDETECT symptoms by average pain severity
by: Sadosky A, et al.
Published: (2016)

Duloxetine in the management of chronic musculoskeletal pain
by: Smith EJ, et al.
Published: (2012)

Pharmacokinetics of duloxetine self-administered in overdose with quetiapine and other antipsychotic drugs in a Japanese patient admitted to hospital
by: Koichiro Adachi, et al.
Published: (2021)

Perverse Incentives in the Medicare Prescription Drug Benefit
by: David McAdams, et al.
Published: (2007)

Acute generalized exanthematous pustulosis induced by duloxetine
by: Numa Deydier, et al.
Published: (2023)

Oral self-administration of pregabalin in a mouse model and the resulting drug addiction features
by: Yusuf S. Althobaiti
Published: (2024)

The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study
by: Ahmed Al-jedai, et al.
Published: (2023)

Pregabalin and uremic pruritus
by: Khichar Purnaram Shubhakaran
Published: (2017)

Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018)

Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
by: Moore N, et al.
Published: (2015)

P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug–herb/drug–drug interactions
by: Liang S, et al.
Published: (2014)

Risk factors of self-reported adverse drug events among Medicare enrollees before and after Medicare Part D
by: Doucette WR, et al.
Published: (2009)

Continuation treatment of major depressive disorder: is there a case for duloxetine?
by: Trevor R Norman, et al.
Published: (2010)

Pregabalin in acute and chronic pain
by: Dalim Kumar Baidya, et al.
Published: (2011)

Premedication dilemmas, is Pregabalin the answer?
by: Preetha Elizabeth George, et al.
Published: (2015)

Drug–Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats
by: Wang Q, et al.
Published: (2019)

Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations
by: Ashley Jaksa, et al.
Published: (2023)

Informing the risk assessment related to lactation and drug exposure: A physiologically based pharmacokinetic lactation model for pregabalin
by: Cameron Humerickhouse, et al.
Published: (2024)

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan
by: Igarashi A, et al.
Published: (2015)

Advances in the treatment of relapsing–remitting multiple sclerosis – critical appraisal of fingolimod
by: Gasperini C, et al.
Published: (2013)

Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
by: Kalpajit Dutta, et al.
Published: (2016)

Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation
by: Amr Mostafa El Sharawy, et al.
Published: (2017)

Duloxetine treatment adherence across mental health and chronic pain conditions
by: Able SL, et al.
Published: (2014)

A case of pregabalin‐induced drug eruptions accompanied by extremely high serum thymus and activation‐regulated chemokine levels
by: Shigeruko Iijima, et al.
Published: (2021)

Low-Income Medicare Beneficiaries and Their Experiences with the Part D Prescription Drug Benefit
by: Noemi V. Rudolph, et al.
Published: (2010)

Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS–TEN overlap and potential drug–drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital
by: Abdulah R, et al.
Published: (2017)

Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans
by: Kim KH, et al.
Published: (2020)

Preparation and evaluation of duloxetine hydrochloride enteric-coated pellets with different enteric polymers
by: Chen Kuang, et al.
Published: (2017)

Optimization of initial dosage of quetiapine in schizophrenic patients: effects of fluvoxamine or duloxetine coadministration
by: Xiao Chen, et al.
Published: (2024)